Rossi L - Search Results

1

Bevacizumab in ovarian cancer: A critical review of phase III studies.

Rossi L, Verrico M, Zaccarelli E, Papa A, Colonna M, Strudel M, Vici P, Bianco V, Tomao F. Rossi L, et al. Oncotarget. 2017 Feb 14;8(7):12389-12405. doi: 10.18632/oncotarget.13310. Oncotarget. 2017. PMID: 27852039 Free PMC article. Review.

2

Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).

Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S. Miele E, et al. Among authors: rossi l. J Exp Clin Cancer Res. 2008 Oct 17;27(1):52. doi: 10.1186/1756-9966-27-52. J Exp Clin Cancer Res. 2008. PMID: 18928537 Free PMC article. Review.

3

The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site.

Spinelli GP, Miele E, Tomao F, Rossi L, Pasciuti G, Zullo A, Zoratto F, Nunnari J, Pisanelli GC, Tomao S. Spinelli GP, et al. Among authors: rossi l. World J Surg Oncol. 2008 Nov 5;6:116. doi: 10.1186/1477-7819-6-116. World J Surg Oncol. 2008. PMID: 18986537 Free PMC article.

4

Current approach in the treatment of hepatocellular carcinoma.

Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, Tomao S. Rossi L, et al. World J Gastrointest Oncol. 2010 Sep 15;2(9):348-59. doi: 10.4251/wjgo.v2.i9.348. World J Gastrointest Oncol. 2010. PMID: 21160806 Free PMC article.

5

Emerging role of cetuximab in the treatment of colorectal cancer.

Papa A, Rossi L, Lo Russo G, Giordani E, Spinelli GP, Zullo A, Petrozza V, Tomao S. Papa A, et al. Among authors: rossi l. Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):233-47. doi: 10.2174/157489212799972882. Recent Pat Anticancer Drug Discov. 2012. PMID: 22264223 Review.

6

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice.

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Di Seri M, Longo F, Mottolese M, Giannarelli D, Ruco L, Romiti A, Barucca V, Adua D, Tomao S. Rossi L, et al. Future Oncol. 2012 Sep;8(9):1193-7. doi: 10.2217/fon.12.108. Future Oncol. 2012. PMID: 23030493

7

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.

Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S. Zoratto F, et al. Among authors: rossi l. Onco Targets Ther. 2012;5:199-211. doi: 10.2147/OTT.S30581. Epub 2012 Sep 24. Onco Targets Ther. 2012. PMID: 23055745 Free PMC article.

8

Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.

De Blasio A, Rossi L, Zappone E, Ortu La Barbera E, Salvatori R, Pacilli M, Carbone A, Zaccarelli E, Papa A, Tomao S. De Blasio A, et al. Among authors: rossi l. Anticancer Drugs. 2013 Jul;24(6):653-7. doi: 10.1097/CAD.0b013e328360cd8c. Anticancer Drugs. 2013. PMID: 23698254

9

Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma.

Bianchi L, Rossi L, Tomao F, Papa A, Zoratto F, Tomao S. Bianchi L, et al. Among authors: rossi l. Endocr Relat Cancer. 2013 Aug 19;20(5):R233-45. doi: 10.1530/ERC-13-0201. Print 2013 Oct. Endocr Relat Cancer. 2013. PMID: 23833016 Review.

10

Current status of bevacizumab in advanced ovarian cancer.

Tomao F, Papa A, Rossi L, Caruso D, Panici PB, Venezia M, Tomao S. Tomao F, et al. Among authors: rossi l. Onco Targets Ther. 2013 Jul 22;6:889-99. doi: 10.2147/OTT.S46301. Print 2013. Onco Targets Ther. 2013. PMID: 23901283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,713 results

Search Page